From 2000 to 2006, he devoted his efforts largely to the work of Neurome, Inc., a biotechnology company he cofounded to develop treatments for such neurodegenerative conditions as Alzheimer???s disease, Parkinson???s disease, Huntington???s disease and amyotrophic lateral sclerosis (ALS or Lou Gehrig???s disease).